Clinical Trials Browser

Breast Carcinoma In Situ × pasireotide × Breast × Clear all

NCT01372644 2016-12-05

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Phase 1 Completed

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating